| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |